Search Results

Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy.

• Authors : Mu-Chun Yang^1,2; Sheng-Kang Chiu^2,3; Jong-Kai Hsiao^2,4

• Source: Journal of Cancer Research & Practice. Jan-Mar2024, Vol. 11 Issue 1, p39-43. 5p.

Record details

Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach.

• Authors : Chen, Chung-Jiah J.¹ (AUTHOR) ; Choi, Michael Y.¹ (AUTHOR) ; Heyman, Benjamin M.² (AUTHOR)

• Source: Cancers. Sep2023, Vol. 15 Issue 18, p4483. 21p.

Record details

Acute myeloid leukemia in the elderly: evaluation of overall survival in 69 consecutive patients.

• Authors : Veneri D; Zanetti F; Franchini M

Subjects: Aged/Aged/Aged/*physiology ; Aged, 80 and over/Aged, 80 and over/Aged, 80 and over/*physiology ; Leukemia, Myeloid/Leukemia, Myeloid/Leukemia, Myeloid/*mortality

• Source: Haematologica [Haematologica] 2002 Apr; Vol. 87 (4), pp. 447-8.Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Print ISSN: 0390-6078

Record details

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

• Authors : López-Guillermo, Armando¹ (AUTHOR); Canales, Miguel Ángel² (AUTHOR); Dlouhy, Ivan¹ (AUTHOR)

• Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p93-100. 8p.

Record details

Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

• Authors : Bastos-Oreiro, Mariana; Gutierrez, Antonio; Cabero, Almudena

Subjects: COLONY-stimulating factors (Physiology); NON-Hodgkin's lymphoma; CYTOPENIA

• Source: Cancers; Apr2024, Vol. 16 Issue 7, p1285, 12p

Record details

CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens.

• Authors : Esposito, Fabiana; Mezzanotte, Valeria; Tesei, Cristiano

Subjects: CARDIOTOXICITY; STATISTICS; MYOCARDIUM

• Source: Cancers; Feb2024, Vol. 16 Issue 3, p563, 16p

Record details

Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United States.

• Authors : Guzauskas, Gregory F.¹ (AUTHOR); Masaquel, Anthony² (AUTHOR); Thuresson, Per-Olof³ (AUTHOR)

• Source: Leukemia & Lymphoma. Jul2019, Vol. 60 Issue 7, p1668-1676. 9p.

Record details

Updates from the 2016 American Society of Hematology annual meeting: practice-changing studies in untreated follicular lymphoma.

• Authors : Owen, C.¹; MacDonald, D.²; Aw, A.³

• Source: Current Oncology. Feb2017, Vol. 24 Issue 1, p52-60. 9p. 3 Diagrams, 4 Charts, 5 Graphs.

Record details

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma.

• Authors : Claustre, Gwladys; Boulanger, Coralie; Maloisel, Frédéric

Subjects: FOLLICULAR lymphoma; CANCER treatment; RITUXIMAB

• Source: Journal of Cancer Research & Clinical Oncology; May2023, Vol. 149 Issue 5, p1883-1893, 11p

Record details

A rare case of primary follicular lymphoma of the spleen.

• Authors : Sarma, Yerraguntla Subrahmanya¹; Sriharibabu, Manne¹ ; Nayak, Samir Ranjan²

• Source: Journal of Dr. NTR University of Health Sciences. Jan-Mar2016, Vol. 5 Issue 1, p59-62. 4p.

Record details